A Carmel-based startup says recent clinical trial results for its medical technology are even better than expected and delivers a critical boost toward the goal line. Fast BioMedical Chief Executive Officer Joe Muldoon details the recent progress with its technology that can measure a patient’s blood volume, or the amount of blood flowing through the circulatory system and what’s next.  

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}